Sun Qingshen, Shi Yue, Wang Fuying, Han Dequan, Lei Hong, Zhao Yao, Sun Quan
a College of Life Science, University Key Laboratory of Microbiology, Heilongjiang University , Harbin , China and.
b Engineering Research Center of Agricultural Microbiology Technology, Ministry of Education , Harbin , China.
J Microencapsul. 2015;32(7):669-76. doi: 10.3109/02652048.2015.1057249. Epub 2015 Sep 7.
To evaluate the protective effects of microencapsulation on Lactobacillus delbrueckii by random, parallel experimental design.
Lincomycin hydrochloride-induced intestinal malfunction mouse model was successfully established; then the L. delbrueckii microcapsule was given to the mouse. The clinical behaviour, number of intestinal flora, mucous IgA content in small intestine, IgG and IL-2 level in peripheral blood were monitored. The histological sections were also prepared.
The L. delbrueckii microcapsule could have more probiotic effects as indicated by higher bifidobacterium number in cecal contents. The sIgA content in microcapsule treated group was significantly higher than that in non-encapsulated L. delbrueckii treated group (p < 0.05). Intestine pathological damage of the L. delbrueckii microcapsule-treated group showed obvious restoration.
The L. delbrueckii microcapsules could relieve the intestinal tissue pathological damage and play an important role in curing antibiotic-induced intestinal flora dysfunction.
采用随机平行实验设计,评估微囊化对德氏乳杆菌的保护作用。
成功建立盐酸林可霉素诱导的肠道功能紊乱小鼠模型;随后给小鼠投喂德氏乳杆菌微囊。监测小鼠的临床行为、肠道菌群数量、小肠黏液IgA含量、外周血IgG和IL-2水平。同时制备组织学切片。
盲肠内容物中双歧杆菌数量增加,表明德氏乳杆菌微囊具有更多的益生菌作用。微囊处理组的sIgA含量显著高于未微囊化德氏乳杆菌处理组(p < 0.05)。德氏乳杆菌微囊处理组的肠道病理损伤有明显恢复。
德氏乳杆菌微囊可减轻肠道组织病理损伤,在治疗抗生素诱导的肠道菌群失调中发挥重要作用。